230 related articles for article (PubMed ID: 2347015)
1. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
[TBL] [Abstract][Full Text] [Related]
2. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state.
Al Omari AA; Al Omari MM; Badwan AA; Al-Sou'od KA
J Pharm Biomed Anal; 2011 Feb; 54(3):503-9. PubMed ID: 20971593
[TBL] [Abstract][Full Text] [Related]
6. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
[TBL] [Abstract][Full Text] [Related]
7. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
Miyake K; Hirayama F; Uekama K
J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
[TBL] [Abstract][Full Text] [Related]
8. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
[TBL] [Abstract][Full Text] [Related]
9. Epimerization and racemization of some chiral drugs in the presence of cyclodextrin and liposomes.
Aso Y; Yoshioka S; Takeda Y
Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2786-9. PubMed ID: 2611938
[TBL] [Abstract][Full Text] [Related]
10. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
[TBL] [Abstract][Full Text] [Related]
11. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
[TBL] [Abstract][Full Text] [Related]
12. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
Green AR; Guillory JK
J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
[TBL] [Abstract][Full Text] [Related]
13. Physical properties of the complexes formed between heptakis(2,6-di-O-methyl)-beta-cyclodextrin, beta-cyclodextrin, and chlorambucil.
Green AR; Miller ES; Guillory JK
J Pharm Sci; 1991 Feb; 80(2):186-9. PubMed ID: 2051328
[TBL] [Abstract][Full Text] [Related]
14. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
Chen JY; Tsai WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
[No Abstract] [Full Text] [Related]
17. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
18. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases.
Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H
J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547
[TBL] [Abstract][Full Text] [Related]
19. Study of the interaction of dithranol with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin in solution and in the solid state.
Cafaggi S; Vallarino M; Caviglioli G; Parodi B; Bignardi G
J Pharm Pharmacol; 1998 Mar; 50(3):257-64. PubMed ID: 9600716
[TBL] [Abstract][Full Text] [Related]
20. Inclusion complexation of artemisinin with alpha-, beta-, and gamma-cyclodextrins.
Wong JW; Yuen KH
Drug Dev Ind Pharm; 2003 Oct; 29(9):1035-44. PubMed ID: 14606667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
